Pharmacological Applications of Salvia Miltiorrhiza in Cardiovascular Health

Salvia miltiorrhiza, commonly known as Danshen, has long been employed in traditional medicine for its pronounced benefits in cardiovascular disorders. Its principal bioactive constituents divide into lipophilic tanshinones (notably Tanshinone IIA, cryptotanshinone and dihydrotanshinone) and hydrophilic phenolic salvianolic acids (particularly salvianolic acid A and B, as well as salvianolate). These compounds exert multifaceted cardioprotective effects, including potent antioxidant activity through reactive oxygen species scavenging and upregulation of endogenous antioxidant enzymes. Anti-inflammatory actions are mediated by inhibition of NF-κB, MAPK and toll-like receptor signalling in vascular endothelium and leukocytes, thereby attenuating endothelial dysfunction and atherosclerotic progression. Vasodilatory and anticoagulant properties arise from modulation of nitric oxide synthase and platelet aggregation pathways. At the myocardial level, protective effects involve suppression of apoptosis, amelioration of ischaemia–reperfusion injury via PI3K/Akt/mTOR modulation, and prevention of cardiac remodelling through anti-fibrotic signalling. In vascular smooth muscle cells, tanshinones inhibit proliferation and migration, limiting neointima formation. Clinically, Danshen preparations, including sodium Tanshinone IIA sulfonate and standardized dripping pills, have been combined with conventional therapies to improve outcomes in angina pectoris, myocardial infarction, hypertension and hyperlipidaemia. Despite low oral bioavailability of certain constituents, advances in sulfonation, nanoformulations and synthetic biology promise enhanced delivery. Overall, Salvia miltiorrhiza represents a model of multi-compound, multi-target cardiovascular therapeutics with global relevance for integrative treatment strategies.

Research from Nature Portfolio

Recent studies have refined extraction and mechanistic understanding of Danshen’s anti-inflammatory capacity. A systematic purification method has yielded a high-purity total tanshinone fraction demonstrating superior inhibition of inflammatory markers in macrophage models and protection against endotoxin-induced organ injury in rodents. Another investigation, using network pharmacology and endothelial assays, revealed that a multi-component Danshen formulation suppresses NF-κB, c-Jun and p38 activation, reducing pro-inflammatory cytokine release in vascular endothelium and elucidating common anti-inflammatory pathways underpinning benefits in both coronary and cerebrovascular disease. A complementary approach identified six combinatorial bioactive compounds within a cardiotonic formula, each contributing to anti-inflammatory efficacy comparable to the complete preparation, underscoring the additive mode of action of Salvia-derived constituents.

Pharmacological Applications of Salvia Miltiorrhiza in Cardiovascular Health publication trend

The graph below shows the total number of articles in pharmacological applications of salvia miltiorrhiza in cardiovascular health across all publications each year (not limited to Nature Index journals).

Technical terms

Tanshinone IIA: A lipophilic diterpene quinone from Salvia miltiorrhiza with anti-inflammatory, antioxidant and vasodilatory effects in cardiovascular tissues.

Salvianolic acid B (Sal B): A water-soluble polyphenolic compound with strong reactive oxygen species scavenging capacity and modulatory effects on antioxidant enzyme expression.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen that, in excess, damage cells and contribute to endothelial dysfunction and atherosclerosis.

Endothelial inflammation: An early step in vascular disease characterised by cytokine-driven activation of endothelial cells, promoting leukocyte adhesion and atherogenesis.

Vascular smooth muscle cell (VSMC): Cells within the vessel wall whose aberrant proliferation and migration contribute to neointimal formation and vessel narrowing in cardiovascular disease.

References

1. Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications. Frontiers in Pharmacology (2019).
2. Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage. Frontiers in Pharmacology (2020).
3. Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from Salvia miltiorrhiza and their anti-inflammatory activities investigation. Scientific Reports (2018).
4. Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection. Scientific Reports (2017).
5. A strategy for the identification of combinatorial bioactive compounds contributing to the holistic effect of herbal medicines. Scientific Reports (2015).
6. Anti‐Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis. Evidence-based Complementary and Alternative Medicine (2014).